Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Chemotherapy-induced cardiotoxicity and mitigation, Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors, and Heart Failure Treatment and Management.
Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogeny
Adjudication of Adverse Cardiovascular Events in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib: Deaths in GLOW or Blowing in the Wind?
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study
Temporal patterns of left ventricular systolic and diastolic metrics changes in adult patients with haematological malignancies treated with chimeric antigen receptor (CAR)-T cells: results from the CARdio-Tox prospective study
Cost-Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in China: A New Pillar in Our Pockets, but at What Price?
Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology
Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment–Related Early Diastolic Dysfunction
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases
Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials
Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases
Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis
Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil
Heart Failure in Long-Term Survivors of Childhood or Adolescent Cancers
Weathering the Cytokine Storm in COVID-19: Therapeutic Implications
Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence
Acute Heart Failure 29 Years After Treatment for Childhood Cancer
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis
Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological Appraisal
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential